Abstract
In these continuing efforts towards the development of disease modifying treatment for microbial diseases, we are targeting acetyl coenzyme-A carboxylase (ACCase) and it is essential for pathogen survival. In present study we reported the docking studies of substituted benzimidazole derivatives with acetyl coenzyme-A carboxylase inhibitor. Docking Studies of Benzimidazole Derivatives as Coenzyme-A Carboxylase (ACCase) Inhibitor
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
